Gerber »

Theravance Biopharma shares owned by Gerber

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Gerber from 13F filings

Historical chart of Gerber investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Gerber consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Gerber

Quarter filed Position value Share count Share price at filing
2024-03-31 $90k 10k 8.97
2023-12-31 $112k 10k 11.24

More positions owned by Gerber

Fidelity Covington Trust Enhanced Intl (FENI)
Ark Etf Tr Innovation Etf (ARKK)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Apple (AAPL)
Amplify Etf Tr Blockchain Ldr (BLOK)
Vanguard Index Fds Total Stk Mkt (VTI)
Microsoft Corporation (MSFT)
Ark Etf Tr Fintech Innova (ARKF)
NVIDIA Corporation (NVDA)
Altimmune Com New (ALT)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Worthington Industries (WOR)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Gerber

Top funds holding Theravance Biopharma

Weiss Asset Management LP[1
Madison Avenue Partners
Vanguard Group
Newtyn Management
Park West Asset Management
D. E. Shaw & Co
Bank of America Corporation
Jacobs Levy Equity Management
Jane Street
Charles Schwab Investment Management
Wellington Management Company
Goldman Sachs Group
Chescapmanager
SG Americas Securities
Highbridge Capital Management

View all funds holding Theravance Biopharma